Could an antibody ease long COVID? new study begins
NCT ID NCT05877508
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 22 times
Summary
This study tests whether a lab-made antibody called AER002 can safely help adults with Long COVID feel better. Long COVID may be caused by leftover virus in the body, and this antibody aims to target that virus. 36 participants will receive either the antibody or a placebo, and researchers will track their physical health and symptoms over 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSF/Zuckerberg San Francisco General Hospital
San Francisco, California, 94110, United States
Conditions
Explore the condition pages connected to this study.